📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. (2013)

First Author: Diffner E

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2012-07-446120

PubMed Identifier: 23327922

Publication URI: http://europepmc.org/abstract/MED/23327922

Type: Journal Article/Review

Volume: 121

Parent Publication: Blood

Issue: 12

ISSN: 0006-4971